Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-3tv5mrPhase 3Recruiting
Phase 3, double-blind trial of oxytocin in postpartum depression (PPD) (2 arms), sponsored by Faculdade de Medicina de Ribeirão Preto. Primary endpoint: Primary endpoint not reported. Started Nov 2015; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-3tv5mr.